A recovery in cough and cold product sales, plus strong demand for dietary supplements helped Bayer Consumer Health post big gains in the first quarter of 2022. Bayer CEO Werner Baumann told the German firm’s Q1 earnings call that the Consumer Health business had “continued its broad-based growth trajectory” over the three months.
Consumer Health sales advanced by 20.8% to €1.51bn ($1.60bn) in the period as Bayer benefited from a favorable comparison with...







